23andMe Launches Its First NIH Funded Study

December 16, 2010
  By Amy Kiefer and Kim Barnholt 23andMe is excited to announce the launch of our first National Institutes of Health (NIH) funded research project. In  the fall of 2010,...
Read More

Genetic Tests Can Reduce Risks From Blood Thinner Warfarin

March 16, 2010
Today at the American College of Cardiology conference in Atlanta, researchers from the Mayo Clinic and Medco Health Solutions, Inc., presented results showing that using genetic testing to guide dosing...
Read More

FDA Updates Label for Commonly Used Blood Thinner to Include Dosing Recommendations Based on Genetics

February 04, 2010
Warfarin (Coumadin ®) is a blood thinner given to people at high risk for the formation of blood clots due to conditions such as deep vein thrombosis, heart valve disease...
Read More

New Study Shows That Genetic Information Can Improve Administration Of Commonly Used Blood Thinner

February 19, 2009
Each time a doctor writes a prescription for warfarin (Coumadin ®), a blood thinner given to about two million people each year in the United States, it’s a guessing game....
Read More